高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Gut microbiome plays a role in immune response to mRNA COVID vaccines
活動日期:2024.01.23
2024.01.23  

Gut microbiome plays a role in immune response to mRNA COVID vaccines

https://reurl.cc/v0anlk

Jan 4 2024Karolinska Institutet

Researchers from Karolinska Institutet in Sweden have discovered that the gut microbiome can influence how well people respond to mRNA COVID vaccines. The study, published in the journal npj Biofilms and Microbiomes, suggests that certain bacteria in the gut can enhance the immune response to the vaccine, whereas other bacteria may weaken it.

The gut microbiome is the collection of microorganisms that live in our digestive tract. It plays an important role in many aspects of our health, such as digestion, metabolism, and immunity. The researchers wanted to find out if the gut microbiome also affects the response to mRNA COVID vaccines. To do this, the researchers collected stool samples from 68 people living with HIV and 75 healthy individuals before their first mRNA COVID vaccine dose.

The researchers analysed the microbiome composition using a technique called 16S rRNA sequencing, which identifies the types and relative abundance of bacteria in the samples. They also measured the levels of antibodies and immune cells that were produced after the vaccination.

We correlated the microbial composition with immune responses and patient characteristics. This comprehensive analysis included age, gender, body mass index and clinical factors for people living with HIV, aiming to understand the complex relationship between gut microbes and vaccine efficacy."

Piotr Nowak, principal investigator, senior physician and associate professor at Karolinska Institutet's Department of Medicine, Huddinge

The results showed that the initial makeup of the gut microbiome could predict the immune response to the vaccine in both groups. They found that a less diverse gut microbiome was associated with a stronger vaccine response, marked by higher levels of spike protein antibodies and spike specific CD4 T-cells. These are key components of the immune system that help to neutralize the virus and prevent severe infection.

The researchers also identified specific bacteria that were linked with better or worse vaccine responses. For example, they found that Lactobacillus, Bacteroides, and Lachnospira were associated with higher antibody and immune cell levels, while Cloacibacillus was associated with lower antibody levels. They also found that Bifidobacterium and Faecalibacterium were microbial markers of individuals with higher antibody levels.

Omics eBook Compilation of the top interviews, articles, and news in the last year.Download the latest edition

According to the researchers, the study highlights the significant role of the gut microbiome in the effectiveness of mRNA COVID vaccines. The findings could lead to developing microbiota-focused treatments to enhance vaccine responses, especially in groups that may have weaker responses, such as the elderly or immunocompromised individuals. The potential strategies could include changing the diet or taking probiotics to improve the gut microbiome and immunity, the researchers suggest.

The study was conducted in collaboration with the Karolinska University Hospital, and SciLifeLab National Genomics Infrastructure in Stockholm, Sweden. The research was funded by Region Stockholm, the Swedish Research Council, and Physicians Against AIDS.

Source:

Karolinska Institutet

Journal reference:

Ray, S., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomesdoi.org/10.1038/s41522-023-00461-w.

共有295筆資料 頁數: 第1頁(共15頁)
編號 標題 新增日期
1 B cell trajectories influence cancer outcomes 2024.05.09
2 AI to publish knowledge: a tectonic shift 2024.04.17
3 費用僅需十分之一!!巴西Fiocruz與美國Caring Cross與聯手,將.. 2024.04.17
4 預測且警示83%受試者按!!羅是將推出可預測血糖變化趨勢的即時.. 2024.04.17
5 Viral Immune Responses Suppress a Gestational Hormone 2024.03.26
6 施貴寶Opdivo(nivolumab)+Yervoy(ipilimumab)用於晚期肝癌一線.. 2024.03.26
7 ‘Damning’ FDA inspection report undermines positive tria.. 2024.03.19
8 2024年最值得期待的十大新藥(二之一):思覺失調、阿茲海默症、.. 2024.03.19
9 Neutrophils: Unraveling their multifaceted roles in inflam.. 2024.03.14
10 諾和諾德與加州生技公司Neomorph簽訂14.6億美元協議,開發心臟.. 2024.03.14
11 Scientists discover the Achilles heel of chemotherapy-resi.. 2024.03.06
12 New research shows promise for urine-based test to detect .. 2024.03.06
13 New method traces primed resistance in cancer via sister c.. 2024.03.06
14 高靈敏度、低偽陽性、無不適感,「正子乳房斷層攝影」有望改.. 2024.03.06
15 高療效卻有高風險副作用!再生元的骨髓瘤雙特異性抗體linvoselt.. 2024.03.06
16 Turning Off Metastasis in Breast Cancer 2024.02.22
17 瞄準減肥市場!再生元(Regeneron)開發單株抗體,降低GLP-1受體.. 2024.02.22
18 Machine learning unlocks personalized approach to early ov.. 2024.02.15
19 開源節流!!羅氏退回Repare抗癌口服候選新藥camonsertib之合作R.. 2024.02.15
20 Gut microbiome plays a role in immune response to mRNA COV.. 2024.01.23
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:2494410